Finding ways to a kinder experience of cancer
Researching GI cancers and potential treatments is laborious work. In this new series, we delve into why our... Read More
“All I wanted was for life to be normal”: Grant’s story
My name is Grant Mundell. I’m 48; I have two beautiful daughters aged 14 and 12, a wonderful... Read More
The cancer striking younger and younger
When 36-year-old mum Anika Millington first started noticing changes in her toilet habits, she did what most would... Read More
“I’m one piece of an enormous puzzle now, moving towards better outcomes”: Rochelle’s story
When Rochelle Hutson was diagnosed with colorectal cancer at just 36, she felt underprepared, to say the least. Living... Read More
Living with cancer and after: Anika’s story
For young mum Anika Millington, a sudden diagnosis of colorectal cancer was life-changing. “I just had a... Read More
10 things about Jodie, one of our newest Community Advisory Panel members
1. I was diagnosed with colorectal cancer… when I turned 44. I was feeling really tired, but I’d... Read More
Jolene’s story: When turning 40 also comes with a shock cancer diagnosis
Hitting the age of 40 can be a bit of a shock for anyone. But what... Read More
Seven ways you made an impact in 2023
With your support, we’re ending 2023 with meaningful impact for people with GI cancer – including the 34,291 people diagnosed in Australia just this year alone – by making treatments not only better, but easier to access. Have a look at what we’ve achieved together. 1. Three new trials opened this... Read More
No right or wrong reaction to cancer: Katie’s story
Four years ago, Katie felt pain between her ribs and upper back. She was initially told it could be... Read More
PemOla awarded grant on World Pancreatic Cancer Day
16 November 2023 We are thrilled to announce the PemOla clinical trial, led by Dr Daniel Croagh, has received... Read More
Patient-centred outcomes: beyond survival rates
Driven by his passion for improving quality of life for patients, Matt chairs the STOPNET trial for patients... Read More
Changes to the AGITG Board – thank you and welcome
With recent changes to the AGITG Board of Directors, the team would like to express our heartfelt gratitude... Read More
New community-funded research aims to reduce treatment burden for rectal cancer patients
Thanks to the trust, dedication and support of the GI cancer community, up to $200,000 has been awarded... Read More
Distant and disparate: rural, regional and remote access to cancer care
Russell may already be familiar to you as our Chief Executive Officer. In this feature, we cover his... Read More
Oesophageal cancer: symptoms and risk factors
Oesophageal cancer is not as well known as some other forms of cancer, but over 1,400 Australians lose... Read More
From idea to innovation: Dr Fiona Chionh on the VADER trial
Dr Fiona Chionh is a medical oncologist at Austin Hospital as well as a clinician-scientist at the Olivia... Read More
DYNAMIC-III trial could provide more effective screening
The potential of liquid biopsies in cancer screening will be tested in the DYNAMIC-III trial, which is... Read More
Colorectal cancer research at the GI Cancer Institute
Australia has one of the highest incidences of colorectal cancer in the world. Also known as bowel cancer,... Read More
What is cholangiocarcinoma?
February is Gallbladder and Bile Duct Cancer Awareness Month and World Cholangiocarcinoma Awareness Day. In everyday life, most... Read More
An exciting year for gut microbiome research
A translational research update from Dr Sarah Hayes: I am pleased to report that 2022 has been... Read More